Term
Tolterodine - Overactive Bladder |
|
Definition
|
|
Term
Oxybutynin - Overactive Bladder |
|
Definition
|
|
Term
Darifenacin - Overactive Bladder |
|
Definition
|
|
Term
Solifenacin - Overactive Bladder |
|
Definition
|
|
Term
Trospium- Overactive Bladder |
|
Definition
|
|
Term
Fesoterodine - Overactive Bladder |
|
Definition
|
|
Term
Flavoxate - Overactive Bladder |
|
Definition
|
|
Term
Propantheline - GI/IBS/Pre-Op |
|
Definition
|
|
Term
Dicyclomine - GI/IBS/Pre-Op |
|
Definition
|
|
Term
Glycopyrrolate - GI/IBS/Pre-Op |
|
Definition
|
|
Term
Tropicamide -mydriasis/cylcoplegia |
|
Definition
|
|
Term
Tropicamide/Hydroxyamphetamine -mydriasis/cylcoplegia |
|
Definition
|
|
Term
Cyclopentolate -mydriasis/cylcoplegia |
|
Definition
|
|
Term
Pancuronium- Non depolarizing blocking agent |
|
Definition
|
|
Term
Succinylcholine - depolarizing blocking agent |
|
Definition
|
|
Term
Norepinephrine - Direct acting NS |
|
Definition
|
|
Term
Epinephrine - Direct acting NS |
|
Definition
(Adrenalin) α1, α2, β1, β2 |
|
|
Term
Isoproterenol - Direct acting NS |
|
Definition
|
|
Term
Dobutamine - Direct acting NS |
|
Definition
|
|
Term
Fenoldopam - Direct acting NS |
|
Definition
|
|
Term
Carvedilol - antioxidant (non class effect) decrease apoptosis |
|
Definition
Coreg β1, β2, possibly α1 |
|
|
Term
Captopril -1st ACEi; caused blood dyscrasia; reduce dose made more effective |
|
Definition
|
|
Term
|
Definition
Vasotec (Enalaprilat - Vasotec I.V.) |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
Losartan - ARB prodrug weak; active metabolite uricosuric reversible |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
Candesartan - ARB prodrug -activated in intestine not kidney irreversible |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
Olmesartan - ARB prodrug activated in intestine not kidney |
|
Definition
|
|
Term
Aliskiren - NOT used for CHF Renin inhibitor |
|
Definition
|
|
Term
Nesiritide - atrial natriurectic factor recombinate form of B-NF dilatione, used for acute decompensated CHF, more cGMP |
|
Definition
|
|
Term
Chlorothiazide -thiazide high dose needed for same efficacy |
|
Definition
|
|
Term
Hydrochlorothiazide (HCTZ) -thiazide low dose needed for same efficacy |
|
Definition
Hydrodiuril, Esidrix, Oretic |
|
|
Term
Methyclothiazide -thiazide |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
Furosemide -loop diuretic |
|
Definition
|
|
Term
Ethacrynic acid -loop diuretic |
|
Definition
|
|
Term
Bumetanide -loop diuretic |
|
Definition
|
|
Term
|
Definition
|
|
Term
Triamterene - K sparing diuretic bind to Na channel no effect on aldosterone |
|
Definition
|
|
Term
Amiloride - K sparing diuretic |
|
Definition
|
|
Term
Spironolactone - K sparing diuretic bind to MR receptor reduce effect on aldosterone |
|
Definition
|
|
Term
Eplerenone - K sparing diuretic similar to spironolactone but no hormone effects |
|
Definition
|
|
Term
Mannitol - osmotic diuretic |
|
Definition
|
|
Term
|
Definition
|
|
Term
Glycerin - osmotic diuretic |
|
Definition
|
|
Term
Acetazolamide - carbonic anhydrase inhibitor |
|
Definition
|
|
Term
Methazolamide - carbonic anhydrase inhibitor |
|
Definition
|
|
Term
Digoxin - cardiac glycoside block Na/K ATPase --> inc Ca toxic |
|
Definition
Lanoxin -yellow 125; white 250 |
|
|
Term
Digoxin Immune Fab Fragments (ovine) - cardiac glycoside |
|
Definition
Digibind (antidote for Dig toxicity) |
|
|
Term
Dopamine - direct & indirect - adrenergic agonist |
|
Definition
|
|
Term
Dobutamine - adrenergic agonist; direct |
|
Definition
|
|
Term
Amrinone -PDE III inhibitor |
|
Definition
|
|
Term
Milrinone -PDE III inhibitor |
|
Definition
|
|
Term
|
Definition
Inhibitors of Cyclooxygenase |
|
|
Term
Clopidogrel - inhibitor of ADP |
|
Definition
|
|
Term
Dipyridamole -PDE V inhibitor |
|
Definition
|
|
Term
Abciximab -GP IIb/IIIb receptor blocking agent chimeric monoclonal Ab FAB frag irreversible |
|
Definition
|
|
Term
Tirofiban -GP IIb/IIIb receptor blocking agent nonpeptide inhibitor; RGD mimic reversible |
|
Definition
|
|
Term
Eptifibatide -GP IIb/IIIb receptor blocking agent synthetic peptide; cyclic RGD peptide; stable reversible |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
Fondaparinux -Indirect Thrombin Inhibitors Injection; only pentasach; need AT3 Kidney; no antidote |
|
Definition
|
|
Term
Rivaroxaban -Indirect Thrombin Inhibitors don't need AT3; PO; liver; |
|
Definition
|
|
Term
|
Definition
Direct Thrombin Inhibitors |
|
|
Term
Recombinant hirudin - Direct Thrombin Inhibitors |
|
Definition
|
|
Term
Bivalirudin - Direct Thrombin Inhibitors doesn't last long |
|
Definition
|
|
Term
Argatroban - Direct Thrombin Inhibitors rapid & short duration |
|
Definition
|
|
Term
Desirudin - Direct Thrombin Inhibitors SQ |
|
Definition
|
|
Term
Dabigatran - Direct Thrombin Inhibitors POBID acid environment required |
|
Definition
|
|
Term
Warfarin - inhibitor of synthesis of Vit K dependent Coagulation factors(2, 7, 9, 10, protein C & S) |
|
Definition
|
|
Term
Streptokinase -Thrombolytic agent NS; nondirect |
|
Definition
|
|
Term
Urokinase -Thrombolytic agent direct; NS; not widely used |
|
Definition
|
|
Term
APSAC (acylated plasminogen streptokinase activator complex) - Thrombolytic agent possible fibrin selective |
|
Definition
|
|
Term
tPA - alteplase -Thrombolytic agent frequent bleeding @ high dose; fibrin selective |
|
Definition
|
|
Term
rPA -reteplase -Thrombolytic agent long duration; less binding & affinity; penetrate longer fibrin selective |
|
Definition
|
|
Term
Tenecteplase -Thrombolytic agent not inhibited by PAI fibrin selective |
|
Definition
|
|
Term
Drotrecogin alfa activated - activated protein C anticoagulant |
|
Definition
|
|
Term
Epsilon aminocaproic acid - binds to lysine-binding sites on both plasminogen and plasmin anticoagulant |
|
Definition
|
|
Term
Aprotinin -taken off market; lots of death; blocked plasmin, tPA & factor 12a anticoagulant |
|
Definition
|
|
Term
Benazepril and amlodipine |
|
Definition
|
|
Term
|
Definition
|
|
Term
Trandolapril and verapamil |
|
Definition
|
|
Term
|
Definition
|
|
Term
Olmesartan and Amlodipine |
|
Definition
|
|
Term
Triamterene / Hydrochlorothiazide |
|
Definition
|
|
Term
|
Definition
|
|
Term
Lisinopril / Hydrochlorothiazide |
|
Definition
|
|
Term
|
Definition
|
|
Term
Valsartan / Hydrochlorothiazide |
|
Definition
|
|
Term
Losartan potassium / Hydrochlorothiazide |
|
Definition
|
|
Term
Olmesartan / Hydrochlorothiazide |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
Trandate, Normodyne B1, B2 maybe a1 |
|
|
Term
Dorzolamide - Carbonic anhydrase inhibitor Gluacoma |
|
Definition
|
|
Term
Brinzolamide - Carbonic anhydrase inhibitor Gluacoma |
|
Definition
|
|
Term
Vaprisol - non selective AVP blocker |
|
Definition
|
|
Term
Samsca - V2 selective AVP blocker |
|
Definition
|
|
Term
Dichlorophenamide - Carbonic anhydrase inhibitor |
|
Definition
|
|
Term
Exanta - Off market, Direct Thrombin Inhibitor |
|
Definition
Ximegalatran- hepatic damage |
|
|
Term
Telmisartan + Hydrochlorothiazide- ARB combination |
|
Definition
|
|
Term
Eprosartan Mesylate + Hydrochlorothiazide ARB combination |
|
Definition
|
|
Term
Irbesartan + HCTZ - ARB combination |
|
Definition
|
|
Term
Dorzolamide and Timolol - Carbonic anhydrase inhibitor Gluacoma |
|
Definition
|
|
Term
|
Definition
diagnostic agent-mydriasis/cylcoplegia |
|
|
Term
Infliximab - Anti TNF chimeric monoclonal AB |
|
Definition
|
|
Term
Adalimumab - Anti TNF chimeric monoclonal AB |
|
Definition
|
|
Term
|
Definition
inhibits activated: 2, 7, 9, 10, 11 & 12 indirect thrombin inhibitors Negative charge- Kidney excretion |
|
|